BACKGROUND:Cognitive behavioral therapy (CBT) is an evidence-based treatment for alcohol use disorders (AUDs), yet is rarely implemented with high fidelity in clinical practice. Computer-based delivery of CBT offers the potential to address dissemination challenges, but to date there have been no evaluations of a web-based CBT program for alcohol use within a clinical sample. METHODS: This study randomized treatment-seeking individuals with a current AUD to 1 of 3 treatments at a community outpatient facility: (i) standard treatment as usual (TAU); (ii) TAU plus on-site access to a computerized CBT targeting alcohol use (TAU + CBT4CBT); or (iii) CBT4CBT plus brief weekly clinical monitoring (CBT4CBT + monitoring). Participant alcohol use was assessed weekly during an 8-week treatment period, as well as 1, 3, and 6 months after treatment. RESULTS:Sixty-eight individuals (65% male; 54% African American) were randomized (TAU = 22; TAU + CBT4CBT = 22; CBT4CBT + monitoring = 24). There were significantly higher rates of treatment completion among participants assigned to 1 of the CBT4CBT conditions compared to TAU (Wald = 6.86, p < 0.01). Significant reductions in alcohol use were found across all conditions within treatment, with participants assigned to TAU + CBT4CBT demonstrating greater increases in percentage of days abstinent (PDA) compared to TAU, t(536.4) = 2.68, p < 0.01, d = 0.71, 95% CI (0.60, 3.91), for the full sample. Preliminary findings suggest the estimated costs of all self-reported AUD-related services utilized by participants were considerably lower for those assigned to CBT4CBT conditions compared to TAU, both within treatment and during follow-up. CONCLUSIONS: This trial demonstrated the safety, feasibility, and preliminary efficacy of web-based CBT4CBT targeting alcohol use. CBT4CBT was superior to TAU at increasing PDA when delivered as an add-on, and it was not significantly different from TAU or TAU + CBT4CBT when delivered with clinical monitoring only.
RCT Entities:
BACKGROUND: Cognitive behavioral therapy (CBT) is an evidence-based treatment for alcohol use disorders (AUDs), yet is rarely implemented with high fidelity in clinical practice. Computer-based delivery of CBT offers the potential to address dissemination challenges, but to date there have been no evaluations of a web-based CBT program for alcohol use within a clinical sample. METHODS: This study randomized treatment-seeking individuals with a current AUD to 1 of 3 treatments at a community outpatient facility: (i) standard treatment as usual (TAU); (ii) TAU plus on-site access to a computerized CBT targeting alcohol use (TAU + CBT4CBT); or (iii) CBT4CBT plus brief weekly clinical monitoring (CBT4CBT + monitoring). Participantalcohol use was assessed weekly during an 8-week treatment period, as well as 1, 3, and 6 months after treatment. RESULTS: Sixty-eight individuals (65% male; 54% African American) were randomized (TAU = 22; TAU + CBT4CBT = 22; CBT4CBT + monitoring = 24). There were significantly higher rates of treatment completion among participants assigned to 1 of the CBT4CBT conditions compared to TAU (Wald = 6.86, p < 0.01). Significant reductions in alcohol use were found across all conditions within treatment, with participants assigned to TAU + CBT4CBT demonstrating greater increases in percentage of days abstinent (PDA) compared to TAU, t(536.4) = 2.68, p < 0.01, d = 0.71, 95% CI (0.60, 3.91), for the full sample. Preliminary findings suggest the estimated costs of all self-reported AUD-related services utilized by participants were considerably lower for those assigned to CBT4CBT conditions compared to TAU, both within treatment and during follow-up. CONCLUSIONS: This trial demonstrated the safety, feasibility, and preliminary efficacy of web-based CBT4CBT targeting alcohol use. CBT4CBT was superior to TAU at increasing PDA when delivered as an add-on, and it was not significantly different from TAU or TAU + CBT4CBT when delivered with clinical monitoring only.
Authors: Richard Saitz; Tibor P Palfai; Naomi Freedner; Michael R Winter; Alexandra Macdonald; John Lu; Al Ozonoff; David L Rosenbloom; William Dejong Journal: Alcohol Alcohol Date: 2006-11-26 Impact factor: 2.826
Authors: Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben Journal: JAMA Date: 2006-05-03 Impact factor: 56.272
Authors: Helen M Pettinati; Roger D Weiss; William Dundon; William R Miller; Dennis Donovan; Denise B Ernst; Bruce J Rounsaville Journal: J Stud Alcohol Suppl Date: 2005-07
Authors: Kathleen M Carroll; Samuel A Ball; Steve Martino; Charla Nich; Theresa A Babuscio; Bruce J Rounsaville Journal: Drug Alcohol Depend Date: 2008-11-28 Impact factor: 4.492
Authors: Brian D Kiluk; Charla Nich; Matthew B Buck; Kathleen A Devore; Tami L Frankforter; Donna M LaPaglia; Srinivas B Muvvala; Kathleen M Carroll Journal: Am J Psychiatry Date: 2018-05-24 Impact factor: 18.112
Authors: Brian D Kiluk; Lara A Ray; Justin Walthers; Michael Bernstein; Jeffery S Tonigan; Molly Magill Journal: Alcohol Clin Exp Res Date: 2019-09-30 Impact factor: 3.455
Authors: Corey R Roos; Kathleen M Carroll; Charla Nich; Tami Frankforter; Brian D Kiluk Journal: Drug Alcohol Depend Date: 2020-05-12 Impact factor: 4.492
Authors: Brian D Kiluk; Tami L Frankforter; Michelle Cusumano; Charla Nich; Kathleen M Carroll Journal: Alcohol Clin Exp Res Date: 2018-06-05 Impact factor: 3.455
Authors: Manuel Paris; Michelle Silva; Luis Añez-Nava; Yudilyn Jaramillo; Brian D Kiluk; Melissa A Gordon; Charla Nich; Tami Frankforter; Kathleen Devore; Samuel A Ball; Kathleen M Carroll Journal: Am J Public Health Date: 2018-09-25 Impact factor: 9.308
Authors: Michelle A Silva; Yudilyn Jaramillo; Manuel Paris; Luis Añez-Nava; Tami L Frankforter; Brian D Kiluk Journal: J Subst Abuse Treat Date: 2019-12-13
Authors: Lina Gega; Dina Jankovic; Pedro Saramago; David Marshall; Sarah Dawson; Sally Brabyn; Georgios F Nikolaidis; Hollie Melton; Rachel Churchill; Laura Bojke Journal: Health Technol Assess Date: 2022-01 Impact factor: 4.014